Roberto Galli
Director of Finance/CFO bij NEWRON PHARMACEUTICALS S.P.A.
Oorsprong van het eerstegraads netwerk van Roberto Galli
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
PricewaterhouseCoopers SpA
 PricewaterhouseCoopers SpA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers SpA is a private company based in Milan, Italy.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Newron Pharmaceuticals US, Inc.
2
| Subsidiary | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Roberto Galli via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| European School of Management & Technology GmbH | College/University | Director/Board Member | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Chairman | |
Saladax Biomedical, Inc.
 Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Miscellaneous Commercial Services | Sales & Marketing | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
ALBA Plc & Co. KGaA
 ALBA Plc & Co. KGaA TruckingTransportation ALBA Plc & Co. KGaA provides waste collection and treatment services. Its services include waste removal, waste management, facility management, recycling steel and other metals which are used for infrastructure, technical, and commercial buildings. The company was founded in 1968 by Franz-Josef Schweitzer and is headquartered in Berlin, Germany. | Trucking | Director/Board Member | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member | |
Hunter-Fleming Ltd.
 Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Roger Williams University | College/University | Undergraduate Degree | |
| MEDCAP AB | Medical Specialties | Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| University of Bonn | College/University | Doctorate Degree Undergraduate Degree | |
| University of Bocconi | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Geneva | College/University | Graduate Degree | |
| University of Milan | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | President | |
| Università Cattolica del Sacro Cuore Campus di Milano | College/University | Undergraduate Degree Graduate Degree | |
| PHARMACOLOG I UPPSALA AB | Electronic Equipment/Instruments | Director/Board Member | |
| H. Turnauer Foundation | Director/Board Member | ||
| Omega Fund Management UK LLP | Chief Operating Officer | ||
Amgen AB
 Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Biotechnology | Chief Executive Officer | |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pygargus AB
 Pygargus AB Miscellaneous Commercial ServicesCommercial Services Part of IQVIA, Inc., Pygargus AB is a Swedish company that provides market research and consulting services for the pharmaceutical sector. The private company is based in Stockholm, Sweden. The company was founded by Ragnar Linder. Pygargus was acquired by IQVIA, Inc. from Ängshöken AB on December 09, 2013. | Miscellaneous Commercial Services | Founder | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member | |
Constantia Flexibles Group GmbH
 Constantia Flexibles Group GmbH Containers/PackagingProcess Industries Constantia Flexibles Group GmbH manufactures and supplies flexible packaging and labels. The company was founded by Richard Teich and Ernest Teich in 1912 and is headquartered in Vienna, Austria. | Containers/Packaging | Director/Board Member | |
| CONSTANTIA FLEXIBLES GROUP GMBH | Metal Fabrication | Director/Board Member | |
| Universitätsklinikum Würzburg | College/University | Director/Board Member | |
| The University of Pennsylvania Law School | College/University | Graduate Degree | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
| ALZECURE PHARMA AB | Biotechnology | Director/Board Member | |
Exenta, Inc.
 Exenta, Inc. Packaged SoftwareTechnology Services Exenta, Inc. provides information technology and services. It offers fashion and soft goods ERP software, product lifecycle management, supply chain management, shop floor control (mobile), warehouse management, enterprise resource planning (ERP), electronic data interchange, Mfg and materials planning services. The company is headquartered in New York, NY. | Packaged Software | Chairman | |
| R Linder Holding AB | Director/Board Member | ||
| Ral Capital Ltd. (United Kingdom) | Director/Board Member |
Statistieken
Internationaal
| Zweden | 16 |
| Verenigde Staten | 9 |
| Duitsland | 8 |
| Italië | 6 |
| Zwitserland | 5 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Process Industries | 3 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 198 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 55 |
| Chairman | 47 |
| Chief Executive Officer | 34 |
Sterkste connecties
| Insiders | |
|---|---|
| Bo Jesper Hansen | 34 |
| Stig Anders Lindberg | 31 |
| Joseph deBethizy | 29 |
| Renée Aguiar-Lucander | 26 |
| Axel Bolte | 23 |
| Pierroberto Folgiero | 23 |
| Patrick J. Langlois | 23 |
| Sergio Duca | 21 |
| Joël Jean-Louis Besse | 20 |
| Marina Rubini | 15 |
| Ulrich Köstlin | 14 |
| Rolf Stahel | 13 |
| Luca Benatti | 12 |
| Luca Maurizio Duranti | 11 |
| Ragnar Linder | 11 |
- Beurs
- Insiders
- Roberto Galli
- Bedrijfsconnecties
